uniQure (NASDAQ:QURE) Coverage Initiated at Chardan Capital
Equities researchers at Chardan Capital initiated coverage on shares of uniQure (NASDAQ:QURE – Get Free Report) in a note issued to investors on Tuesday, Marketbeat Ratings reports. The brokerage set a “buy” rating and a $38.00 price target on the biotechnology company’s stock. Chardan Capital’s price target points to a potential upside of 257.82% from […]
Equities researchers at Chardan Capital initiated coverage on shares of uniQure (NASDAQ:QURE – Get Free Report) in a note issued to investors on Tuesday, Marketbeat Ratings reports. The brokerage set a “buy” rating and a $38.00 price target on the biotechnology company’s stock. Chardan Capital’s price target points to a potential upside of 257.82% from […]
